Confirmation of the utility of the CA-125 elimination rate (KELIM) as an indicator of the chemosensitivity in advanced-stage ovarian cancer in a "real-life setting"

CONCLUSION: The value of KELIM, as a pragmatic indicator of response to chemotherapy, was maintained in a large real-life population-based cohort, highlighting its applicability in routine conditions.PMID:38216134 | DOI:10.3802/jgo.2024.35.e34

Source: Journal of Gynecologic Oncology - January 12, 2024 Category: OBGYN Authors: Lilian van Wagensveld Olivier Colomban Maaike A van der Aa Gilles Freyer Gabe S Sonke Roy F P M Kruitwagen Benoit You Source Type: research